您的当前位置:首页 > 行业数据 > 国内以淋巴瘤(MCL)为适应症的BTK抑制剂进展
图片属性
图片格式:PNG 图片大小:304KB 图片尺寸:2302*1218
同报告图片
 / 4
国内以淋巴瘤(MCL)为适应症的BTK抑制剂进展_第1页
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
国内以淋巴瘤(MCL)为适应症的BTK抑制剂进展_第2页
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
国内以淋巴瘤(MCL)为适应症的BTK抑制剂进展_第3页
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
国内以淋巴瘤(MCL)为适应症的BTK抑制剂进展_第4页
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
国内以淋巴瘤(MCL)为适应症的BTK抑制剂进展_第5页
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
所属报告: 首药控股-公司研究报告-三代ALK和RET有望成为首款国产产品-230208(30页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠